New brain bleed treatment shows promise in major trial

NCT ID NCT07208097

Recruiting now Disease control Sponsor: Tongji Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to treat a serious type of brain bleed (intracerebral hemorrhage). It compares standard medical care to a minimally invasive procedure that uses a small tube to drain the blood clot and deliver a clot-busting drug (tenecteplase). The goal is to see if this approach helps more people recover with less disability after 6 months. The trial plans to enroll 768 adults aged 18-80 with a specific size of brain bleed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HAEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACEREBRAL HAEMORRHAGE MINIMALLY INVASIVE TREATMENT

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Guizhou Medical University Affiliated Hospital
ACTIVE_NOT_RECRUITING

Guiyang, Guizhou, 550000, China
Suzhou First People's Hospital
RECRUITING

Suzhou, Anhui, 234000, China

Contact Phone: •••-•••-•••• Email: •••••@•••••